Who owns CONTEXT THERAPEUTICS INC COM?
- Ticker: CNTX
- CUSIP Number: 21077p108
Tip: Access positions for across all investors
Analyze quarterly positions in Context Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Context Therapeutics stock
Who bought or sold CONTEXT THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Opaleye Management | 1.1M | $1.5M | 14% | Mar 2024 |
|
| Vanguard Group | 598k | $826k | 0% | Mar 2024 |
|
| UBS O'Connor | 297k | $409k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 206k | $284k | 100% | Mar 2024 |
|
| HighTower Advisors | 126k | $174k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 106k | $146k | 0% | Mar 2024 |
|
| Geode Capital Management | 101k | $140k | 4% | Mar 2024 |
|
| Northern Trust | 37k | $51k | 0% | Mar 2024 |
|
| Clear Harbor Asset Management | 36k | $50k | 0% | Mar 2024 |
|
| Susquehanna International | 22k | $31k | 100% | Mar 2024 |
|
| Sheets Smith Wealth Management | 20k | $28k | 0% | Mar 2024 |
|
| Citadel Advisors | 15k | $21k | -5% | Mar 2024 |
|
| Leucadia National Corporation | 12k | $16k | 100% | Mar 2024 |
|
| XTX Topco | 10k | $14k | -23% | Mar 2024 |
|
| Tower Research Capital | 6.4k | $8.8k | -29% | Mar 2024 |
|
| Advisor Group Holdings | 1.5k | $2.1k | 0% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 400.00 | $552.000000 | 100% | Mar 2024 |
|
| Retirement Group | 155.00 | $213.993000 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 116.00 | $159.998800 | 2% | Mar 2024 |
|
| Jpmorgan Chase & Co | 33.00 | $45.998700 | 43% | Mar 2024 |
|
Who sold out of Context Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Aspire Wealth Management Corp | Dec 2023 | 10k | $11k |
| UBS Group | Dec 2023 | 9.5k | $11k |
| Bank of America Corporation | Dec 2023 | 109.00 | $121.109900 |